India, Aug. 19 -- Moderna shares skyrocketed roughly 85% to 95% in pre-market and early trading, nearly doubling in value after Moderna and partner Merck reported positive Phase 3 results for their personalized mRNA skin-cancer vaccine. Here's what investors should watch in the Moderna Stock Price today.

Moderna Stock Rises Higher

Moderna shares rocketed over 80% higher today, trading at $115.06 following groundbreaking late-stage clinical trial results for its personalized mRNA skin-cancer vaccine. This monumental surge represents the first-ever successful final-stage study for any mRNA-based cancer therapy, positioning Moderna to aggressively diversify its business beyond its declining COVID-19 franchise.

Moderna Stock Price Today: C...